Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
about
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancerFamciclovir for ophthalmic zoster: a randomised aciclovir controlled studyGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveProphylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection.Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in children using a relatively short duration of acyclovir prophylaxis: A retrospective study.Herpes latency, meningitis, radiculomyelopathy and disseminated infection.A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea.Chemotherapy for herpes simplex virus infectionsAcyclovir in the prevention of duodenal ulcer recurrence.Herpes simplex and varicella zoster viruses: forgotten but not gone.Prevention and treatment of viral infections in stem cell transplant recipients.Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.Prevention of viral infections after bone marrow transplantation.Treatment of herpesvirus infections in HIV-infected individuals.Acyclovir prophylaxis for herpes simplex virus infection.Mucocutaneous infections with herpes simplex virus and their management.Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.Combating infections in hematopoietic stem cell transplant recipients.Antiviral therapy: current concepts and practicesPhase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantationOral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation.Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trialInfectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients.Herpesvirus and enteric viral infections in bone marrow transplantation: clinical presentations, pathogenesis, and therapeutic strategies.A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.Cytomegalovirus and other herpesviruses infections in heart and bone marrow transplant recipients.Therapeutic progress--review XXVI. Drug therapy for the acute leukaemias.Problems of intensive therapy in childhood cancer.Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions.Viral infections in severely immunocompromised cancer patients.Viral infections in leukemia and bone marrow transplant patients.Infections in cancer patients: some controversial issues.The acyclovir legacy: its contribution to antiviral drug discovery.Acyclovir: is it an effective virostatic agent for orofacial infections?
P2860
Q24241443-7F51355D-1FA8-4BE0-A17C-E6E6907B42D2Q28363444-C07C8A46-1F5D-4228-96C6-5952FFC2D1CAQ28388806-0FC173FD-C79E-4943-9609-04B01A141CC2Q33370617-594E2CF6-9589-451A-AC02-CAF652BA7E00Q33621313-0E0A5253-2AC2-4612-9F7D-FA14EFFE7E33Q33935057-D6ED2C2B-B1A7-4BB0-8BE6-D491D1DA3909Q34120597-C019D05F-99F0-4F11-99DC-7CEFD3EC1333Q34193041-A8258CC4-5DEC-497F-991C-5F99C05CDAD8Q34391851-13E31523-7ECB-4140-8212-AB0FE463FAD1Q34613055-4DB963F6-81CB-4329-A7E3-62679DF27C84Q34722706-9111117B-EEDE-4A12-A10F-A81C28792DDDQ35033597-AA31F1B9-9B64-43F0-B3DB-1E14874181BDQ35230842-E34026CD-A0F4-46D3-AA12-8AFEF9E27CEFQ35231928-ACB7D9EE-094F-4971-B2DB-5DB7CAE61AD9Q35537506-511ABB26-6FF9-4D43-8FCE-B56827E79653Q35545099-BC67992C-BEB3-4FFB-934F-DEC5FF360511Q35809290-56A67C04-2B24-4494-A8AB-C231265F6528Q35917135-E2680978-6ABF-43BB-9487-E6760BFC1CBAQ36070394-35947BA8-B37C-4695-B916-251929C4BE60Q36140983-DE77A8FD-22C7-4668-B45D-5AA5F1D554A1Q36467322-52C79F19-249C-47A6-9D9A-75BE843B7AC7Q36478736-C0839E4B-30A5-4C52-B8FC-75BBEA0463CBQ36560134-E0796D9F-FBA1-4680-9AD5-08FF9F8B9BC0Q36903422-27758075-D09F-4EA6-94F9-413BDC4EA0EEQ37150434-8354310F-8E49-454A-8C51-58EDFCEAA7EDQ37182608-DC29DEAB-3BF7-46F3-9B81-BD243770C647Q37899125-67FD6200-99E6-4F2C-8A45-74303CCAE62DQ37901418-A55DD60F-3BC8-4436-95BE-A73338022F35Q39010658-1C0B6DE9-5B62-4C86-B970-4D226FA890DBQ39584883-C111A5EF-56AB-4E97-BF26-4625B351AE78Q39663018-4E0BC00D-B9B8-419D-A1A6-A2349A1174A5Q39735953-C040ABB1-FF74-4BC7-A079-7EDDAD56F2D6Q39879440-5D08C7F0-8D89-4A53-BA2C-3014B7D94174Q40222954-C441AACF-315F-4E4F-AB68-E867C53A1551Q40284011-B3207D57-3B62-424C-A668-B50D4EDDF2CAQ40594928-AFE4FF34-1B43-40DA-9965-AB77AEE1350DQ40722959-57B9DF6D-ECF1-41A6-8F1F-9B65B511F2D2Q40739451-F3D825EA-D4B6-4DBA-AF7D-568A244B5D21Q40782470-FFAF7C0E-BD59-441A-B4DF-BC0743B30D08Q40811393-9030A393-4DBC-455D-A9EF-1AA4DA8580CF
P2860
Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
Oral acyclovir for prevention ...... after marrow transplantation.
@en
Oral acyclovir for prevention ...... after marrow transplantation.
@nl
type
label
Oral acyclovir for prevention ...... after marrow transplantation.
@en
Oral acyclovir for prevention ...... after marrow transplantation.
@nl
prefLabel
Oral acyclovir for prevention ...... after marrow transplantation.
@en
Oral acyclovir for prevention ...... after marrow transplantation.
@nl
P2093
P1476
Oral acyclovir for prevention ...... after marrow transplantation.
@en
P2093
P304
P356
10.7326/0003-4819-100-6-823
P407
P577
1984-06-01T00:00:00Z